Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
GeneFrontier Japan
Sakai, Japan
A
- Employees
2010
Key takeaway
The company specializes in protein engineering and biologics, highlighting its innovative approaches to developing novel biopharmaceutical candidates, including high-performance antibodies and cyclic peptides.
Reference
Product
Drug Discovery | 日本語版
Molcure
Tokyo, Japan
A
11-50 Employees
2013
Key takeaway
The company has amassed over 1 billion proprietary biopharmaceutical data points through advanced lab techniques and AI technology, enabling the identification of valuable antibodies and peptides. Their use of directed evolution experiments and machine learning models allows for accurate predictions of biopharmaceutical properties such as affinity and immunogenicity, thereby accelerating drug discovery.
Reference
Core business
Molcure Inc. | Accelerating drug discovery
Kaytee Bio
Chiba, Japan
A
- Employees
-
Key takeaway
Kaytee Bio is a biotech company focused on developing innovative diagnostics and medicines, particularly for conditions like rheumatoid arthritis. Their work highlights the need for advanced biological products and early diagnostic tools to enhance treatment outcomes.
Reference
Core business
Diagnosis and treatment of rheumatoid arthritis - Kaytee Bio - kaytee Bio
Kaytee Bio is a biotech company who develop diagnostic tools and treatment of rheumatoid arthritis
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
mAbProtein
Izumo, Japan
A
1-10 Employees
2018
Key takeaway
mAbProtein is a biopharmaceutical company focused on driving innovation in antibody development, aiming to support patients, doctors, and researchers.
Reference
Core business
マブプロテイン｜抗体製造 mAbProtein | 島根大学発のバイオベンチャー
Libra Medicina
Sapporo, Japan
A
1-10 Employees
2009
Key takeaway
LibraMedicina Ltd. is dedicated to improving health and the quality of life for patients, particularly through its intermediary services for contract R&D and GMP manufacturing of biopharmaceuticals. Their focus on creating new medicines and medical devices offers hope to those suffering from serious illnesses.
Reference
Core business
Company Profile - リブラメディシーナ
Minaris Regenerative Medicine
Tokyo, Japan
A
501-1000 Employees
-
Key takeaway
Minaris Regenerative Medicine is a prominent contract development and manufacturing organization specializing in the production of cell and gene therapy products. With over 20 years of experience, they provide clinical and commercial manufacturing services, ensuring high quality and reliability for life-changing therapies distributed worldwide.
Reference
Service
QP Batch Certification | Minaris Regenerative Medicine
For cell and gene therapy products manufactured outside the European Union, Minaris Regenerative Medicine offers batch release to the EU market by Qualified Persons (QP).
Arigen Pharmaceuticals
Tokyo, Japan
A
11-50 Employees
2001
Key takeaway
The company focuses on innovative trifunctional CIRs that selectively mark serum antibodies and direct immune responses towards specific target proteins, which is highly relevant in the biopharmaceutical sector. Additionally, they emphasize process improvements in drug development to enhance the success rate of preclinical candidates.
Reference
Product
Process Products for the Life Science Industry ⇒ bionity.com
CMIC Group
Tokyo, Japan
A
5001-10000 Employees
1992
Key takeaway
Moffitt Cancer Center and CMIC Group have formed a strategic partnership that enhances their capabilities in biopharmaceuticals, providing a wide range of services from preclinical research to practical applications. CMIC, as Japan's leading Contract Research Organization, offers customized solutions for various stakeholders in the pharmaceutical and medical fields.
Reference
Product
CMIC Group | Contract Development and Manufacturing (CDMO)
CMIC Group's drug development expertise with advanced manufacturing and packaging platforms help accelerate your drug development timeline.
Eolas Biosciences Co. Ltd.
Matsudo, Japan
A
1-10 Employees
2005
Key takeaway
Eolas Biosciences is a business development firm that specializes in the drug discovery and pharmaceutical research market, assisting innovative pharmaceutical research technologies in succeeding in the Japanese market.
Reference
Core business
Business Areas | Eolas Biosciences Co. Ltd.
BioFuture
Tokyo, Japan
A
1-10 Employees
1995
Key takeaway
The company, BioFuture, specializes in solid biopharmaceuticals, offering innovative solutions to everyday challenges through biotechnology. Their product range includes various forms of solid bio formulations.
Reference
Product
固形バイオ製剤 – 有限会社バイオフューチャー
Technologies which have been searched by others and may be interesting for you:
The biopharmaceutical industry in Japan is influenced by several key considerations that are essential for anyone looking to engage with companies in this field. Regulatory frameworks in Japan are stringent and involve thorough approval processes governed by the Pharmaceuticals and Medical Devices Agency (PMDA), which ensures that products meet safety and efficacy standards. Understanding these regulations is crucial when navigating the market. Challenges include a rapidly aging population, which drives demand for innovative therapies, but also increases competition among firms. Additionally, companies must be aware of environmental concerns and sustainability practices, as there is growing scrutiny on the ecological impact of biopharmaceutical manufacturing processes. Opportunities abound in Japan due to strong governmental support for research and development, particularly in regenerative medicine and personalized therapies. The country is also a significant player in the global market, with increasing international collaborations and partnerships that enhance innovation. Finally, the competitive landscape is characterized by both established firms and emerging biotech companies, making it important for newcomers to identify niche areas where they can differentiate themselves. Being informed about these factors will provide a solid foundation for anyone interested in the biopharmaceutical sector in Japan.
Some interesting numbers and facts about your company results for Biopharmaceutical
| Country with most fitting companies | Japan |
| Amount of fitting manufacturers | 27 |
| Amount of suitable service providers | 20 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1992 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for Biopharmaceutical
What are related technologies to Biopharmaceutical?
Based on our calculations related technologies to Biopharmaceutical are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Biopharmaceutical?
The most represented industries which are working in Biopharmaceutical are Other, Biotechnology, Pharmaceuticals, IT, Software and Services, Chemicals
How does ensun find these Biopharmaceutical Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.